Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review

[21] Mohey H(2005)Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy Kidney Int 68 802-405

[22] Laurent B(2005)The therapeutic effects of mycophenolate mofetil for advanced IgA nephropathy Inner Mongolia Med J 37 1016-513

[23] Mariat C(2007)Mycophenolate mofetil versus intermittent cyclophosphamide pulse therapy in patients with crescentic IgA nephropathy Shen zang bing yu tou xi shen yi zhi za zhi 16 401-102

[24] Afiani A(2010)Comparison of the therapeutic effects of leflunomide and mycophenolate mofetil in the treatment of immunoglobulin A nephropathy manifesting with nephrotic syndrome Int J Clin Pharmacol Ther 48 509-549

[25] Thibaudin L(2014)Treatment of severe IgA nephropathy: mycophenolate mofetil/prednisone compared to cyclophosphamide/prednisone Int J Clin Pharmacol Ther 52 95-203

[26] Ginzler EM(2010)Long-term study of mycophenolate mofetil treatment in IgA nephropathy Kidney Int 77 543-2872

[27] Dooley MA(2012)Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression J Nephrol 25 198-301

[28] Aranow C(2008)Delayed severe pneumonia in mycophenolate mofetil-treated patients with IgA nephropathy Nephrol Dial Transplant 23 2868-undefined

[29] Kim MY(1996)End-stage renal disease in China Kidney Int 49 287-undefined

[30] Buyon J(undefined)undefined undefined undefined undefined-undefined

[21] Mohey H(2005)Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy Kidney Int 68 802-405

[22] Laurent B(2005)The therapeutic effects of mycophenolate mofetil for advanced IgA nephropathy Inner Mongolia Med J 37 1016-513

[23] Mariat C(2007)Mycophenolate mofetil versus intermittent cyclophosphamide pulse therapy in patients with crescentic IgA nephropathy Shen zang bing yu tou xi shen yi zhi za zhi 16 401-102

[24] Afiani A(2010)Comparison of the therapeutic effects of leflunomide and mycophenolate mofetil in the treatment of immunoglobulin A nephropathy manifesting with nephrotic syndrome Int J Clin Pharmacol Ther 48 509-549

[25] Thibaudin L(2014)Treatment of severe IgA nephropathy: mycophenolate mofetil/prednisone compared to cyclophosphamide/prednisone Int J Clin Pharmacol Ther 52 95-203

[26] Ginzler EM(2010)Long-term study of mycophenolate mofetil treatment in IgA nephropathy Kidney Int 77 543-2872

[27] Dooley MA(2012)Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression J Nephrol 25 198-301

[28] Aranow C(2008)Delayed severe pneumonia in mycophenolate mofetil-treated patients with IgA nephropathy Nephrol Dial Transplant 23 2868-undefined

[29] Kim MY(1996)End-stage renal disease in China Kidney Int 49 287-undefined

[30] Buyon J(undefined)undefined undefined undefined undefined-undefined